Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Market Pain, Strategic Gain: Pilbara Minerals’ Dale Henderson... June 28, 2025 Top 10 Gold Reserves by Country May 16, 2025 5 Best-performing Canadian Pharma Stocks of 2025 July 30, 2025 Blue Lagoon Resources Officially Opens Dome Mountain Gold... July 12, 2025 Issue of Shares and Cleansing Notice June 27, 2025 Placement Shares Issued & Drilling Approval Expected August July 10, 2025 5 Best-performing Canadian Uranium Stocks of 2025 August 6, 2025 Mobile Gaming Stocks: 10 Biggest Companies in 2025 June 17, 2025 5 Best-performing Canadian Oil and Gas Stocks of... July 24, 2025 Top 10 Silver-producing Countries August 20, 2025